Defiance Nasdaq Junior Biotechnology ETF (IBBJ)
Defiance Nasdaq Junior Biotechnology ETF operates in the Asset Management industry of the Financial Services sector, headquartered in DE, US. The stock last traded at $29.87, down 0.07% on the session, giving a market capitalisation of $8.2M. Its beta of 0.00 implies it has historically moved less than the broad market.
This investment vehicle's primary objective is to track the overall performance, measured by total return, of the NASDAQ Junior Biotechnology Index, before accounting for any associated fees or expenses. The index itself is a rule-based compilation of U.S.-listed small-capitalization ("junior") biotechnology companies, carefully selected from the broader spectrum of businesses found within the NASDAQ Biotechnology Index. The fund typically implements a "replication" investment strategy, which means it generally acquires positions in all the component securities of its benchmark index, aiming to maintain their proportional weightings. This fund is designated as non-diversified.
Defiance Nasdaq Junior Biotechnology ETF is most often compared with the following Financial Services names: